INGNHIGH SIGNALOPERATIONAL10-K

INGN's operating cash flow plummeted from $5.9M positive to -$11.2M negative, indicating a severe deterioration in core business cash generation despite improving net losses.

The dramatic swing from positive to deeply negative operating cash flow represents a material operational setback that threatens the company's ability to self-fund operations. While net losses improved, the cash flow deterioration suggests potential collection issues or working capital management problems that could force additional financing needs.

Comparing 2026-02-27 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

INGN showed mixed financial performance with net losses improving 37% to -$22.7M and operating losses narrowing 29% to -$30.2M, indicating better expense management. However, the company's cash generation collapsed with operating cash flow swinging negative by nearly $17M, while accounts receivable surged 32% to $38.9M, suggesting potential collection challenges. The balance sheet strengthened with debt reduction of 49%, lower total liabilities, and higher stockholders' equity, but the severe cash flow deterioration overshadows these improvements and signals urgent operational concerns.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-289.7%
$5.9M-$11.2M

Operating cash flow fell 289.7% — earnings quality concerns; investigate working capital changes and non-cash items.

Interest Expense
P&L
-72.7%
$22K$6K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Total Debt
Balance Sheet
-48.7%
$614K$315K

Debt reduced 48.7% — deleveraging strengthens balance sheet and reduces financial risk.

Net Income
P&L
+36.6%
-$35.9M-$22.7M

Net income grew 36.6% — bottom-line growth signals improving overall business health.

Accounts Receivable
Balance Sheet
+31.5%
$29.6M$38.9M

Receivables surged 31.5% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Operating Income
P&L
+29%
-$42.5M-$30.2M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Capital Expenditure
Cash Flow
-24.9%
$3.4M$2.5M

Capex reduced 24.9% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Liabilities
Balance Sheet
-17.1%
$76.7M$63.5M

Current liabilities reduced — improved short-term financial position and working capital health.

Total Liabilities
Balance Sheet
-13%
$122.3M$106.4M

Liabilities reduced 13% — deleveraging improves balance sheet strength and financial flexibility.

Stockholders Equity
Balance Sheet
+10.6%
$173.9M$192.2M

Equity base grew 10.6% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-02-28
ADDED
We own a pending application for the mark Inogen in Thailand.
We own trademark registrations for the mark Rove in Argentina, Australia, China, Colombia, Europe (European Union Registration), Indonesia, Mexico, Saudi Arabia, and the United Kingdom.
We own pending applications for the mark Rove in Brazil, Canada, India, and South Korea.
We own trademark registrations for the mark Inogen Rove in Australia, China, Colombia, Europe (European Union Registration), Indonesia, Mexico, Saudi Arabia, and the United Kingdom.
We own pending applications for the mark Inogen Rove in Argentina, Brazil, Canada, India, and South Korea.
+7 more — sign up free →
REMOVED
We own pending applications for the mark Inogen in Indonesia, Taiwan, Thailand, the UAE and Vietnam.
PHYSIOASSIST, the Physio-Assist logo, SIMEOX, SIMEOX PRO, HOME SIMEOX, SIMESOFT, PHYSIOWEB, PHYSIODATA, PHYSIOSERVICES, and the Pissenlit logo are registered trademarks of Inogen s wholly-owned subsidiary Physio-Assist.
Physio-Assist owns pending applications for the mark SIMEOX in Argentina, Canada, Colombia, Mexico, Norway, and Switzerland.
Physio-Assist owns trademark registrations in France for the marks PHYSIOASSIST, SIMESOFT, SIMEOX, HOME SIMEOX, SIMEOX PRO, PHYSIOWEB, PHYSIODATA, PHYSIOSERVICES, the Physio-Assist logo, and the Pissenlit logo.
In this Annual Report on Form 10-K, the Company , we, us, and our refer to Inogen, Inc.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →